PERTH, Australia – Following its IPO in August, Melbourne-based Adalta Pty Ltd. inked two deals this month, and is now moving to the clinic with its human version of the shark antibody platform, the i-body.
PERTH, Australia – Following its IPO in August, Melbourne-based Adalta Pty Ltd. inked two deals this month, and is now moving to the clinic with its human version of the shark antibody platform, the i-body.
PERTH, Australia – Although industry rated Australia's Therapeutics Goods Administration (TGA) high when it comes to performing its role ethically and with integrity, the agency has a ways to go when it comes to communicating with its stakeholders, a recent survey suggests.
PERTH, Australia – Although industry rated Australia's Therapeutic Goods Administration (TGA) high when it comes to performing its role ethically and with integrity, the agency has a ways to go when it comes to communicating with its stakeholders, a recent survey suggests.
MELBOURNE, Australia – With the global regenerative medicine market growing at 23 percent annually, Australia is well-positioned to play a significant role in that market, experts said during the AusBiotech conference.
MELBOURNE, Australia – Some big deals in the biopharma space in Australia over the last year have gotten the attention of big pharma, and the sector is keyed up over the courtship possibilities.
MELBOURNE, Australia – With the global regenerative medicine market growing at 23 percent annually, Australia is well-positioned to play a significant role in that market, experts said during the AusBiotech conference.